Michael Steven Niederman, MD

NPI 1073675005ActiveIndividual· Internal Medicine, Pulmonary Disease· New York, NY

Internal Medicine, Pulmonary Disease (MD) in New York, New York, trained at Boston University School of Medicine (class of 1977). Their prescriptions cost Medicare Part D more than their services did: $572,432 for 1,479 claims, against $87,274 paid for services in 2024. Glaxosmithkline, LLC. was the largest of 3 companies reporting payments in 2025, $2,125 in all, mostly consulting fees.

Overview

NPI	1073675005
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Dec 15, 2006
Last updated in NPPES	Jun 27, 2023
Certified by provider	Jun 27, 2023

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	155253	NY
Internal Medicine, Critical Care Medicine	207RC0200X	155253	NY

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (NY)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	343
Services billed	822 across 13 procedure codes
Paid by Medicare	$87,274

Part D prescriptions in 2024

Prescriptions (claims)	1,479 · 1,936 30-day fills
Patients	247
Total drug cost	$572,432

Medicare sources and data years

Education and affiliations

Medical school	Boston University School of Medicine
Graduation year	1977
Medicare specialty	Pulmonary Disease
Secondary specialties	Critical Care (Intensivists)
Telehealth	Offers telehealth